IWP
IMGN

Icon Wealth Partners’s Immunogen Inc IMGN Stock Holding History

Icon Wealth Partners’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,837
Closed -$13K – 818
2019
Q1 		$13K Buy
+4,837
New +$21K ﹤0.01% 637
2018
Q3 		– Sell
-2,814
Closed -$27K – 757
2018
Q2 		$27K Buy
+2,814
New +$29.7K 0.01% 525
2018
Q1 		– Sell
-3,718
Closed -$24K – 773
2017
Q4 		$24K Buy
+3,718
New +$22.9K 0.01% 576

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Icon Wealth Partners's IMGN Position: Q2 2019 in Review

Icon Wealth Partners sold out of Immunogen Inc (IMGN) in Q2 2019, closing a stake of 4,837 shares — an estimated $13K sold.

Icon Wealth Partners first reported a position in IMGN in Q4 2017 and held it in 3 quarters. The position peaked at $27K in Q2 2018. 192 funds tracked by Wall St. Rank hold IMGN as of Q2 2019.

  • Icon Wealth Partners reported no remaining Immunogen Inc position as of Q2 2019 after selling out during the quarter.
  • Icon Wealth Partners sold 4,837 Immunogen Inc shares in Q2 2019, an estimated $13K.
  • Icon Wealth Partners first reported a position in Immunogen Inc in Q4 2017 and held it in 3 quarters.
  • Icon Wealth Partners's Immunogen Inc position peaked at $27K in Q2 2018.
  • 192 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2019.

Based on Icon Wealth Partners's 13F filing for Q2 2019, filed 13 Aug 2019.